Israel Englander Myriad Genetics Inc Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$17.98 - $25.47 $3.42 Million - $4.84 Million
-190,000 Reduced 86.36%
30,000 $733,000
Q1 2024

May 15, 2024
BUY
$17.59 - $23.59 $2.11 Million - $2.83 Million
120,000 Added 120.0%
220,000 $4.69 Million
Q4 2023

Feb 14, 2024
BUY
$13.91 - $21.32 $1.39 Million - $2.13 Million
100,000 New
100,000 $1.91 Million
Q1 2023

May 15, 2023
BUY
$15.26 - $23.75 $311,304 - $484,500
20,400 New
20,400 $474,000
Q3 2022

Nov 14, 2022
SELL
$18.21 - $27.88 $2.21 Million - $3.39 Million
-121,500 Reduced 85.68%
20,300 $387,000

Others Institutions Holding MYGN

# of Institutions
232
Shares Held
92.6M
Call Options Held
117K
Put Options Held
113K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.22B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email